ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 316 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,692,234 | -24.6% | 137,411 | 0.0% | 0.40% | +19.8% |
| Q2 2023 | $4,900,076 | +40.4% | 137,411 | 0.0% | 0.34% | +39.7% |
| Q1 2023 | $3,490,239 | +62527.7% | 137,411 | 0.0% | 0.24% | -62.3% |
| Q4 2022 | $5,573 | -99.9% | 137,411 | 0.0% | 0.64% | +28.1% |
| Q3 2022 | $4,541,000 | -6.1% | 137,411 | 0.0% | 0.50% | +3.1% |
| Q2 2022 | $4,838,000 | -23.4% | 137,411 | 0.0% | 0.49% | +11.7% |
| Q1 2022 | $6,320,000 | -30.6% | 137,411 | 0.0% | 0.44% | -20.8% |
| Q4 2021 | $9,110,000 | +6.2% | 137,411 | 0.0% | 0.55% | +42.6% |
| Q3 2021 | $8,579,000 | -24.6% | 137,411 | 0.0% | 0.38% | -21.9% |
| Q2 2021 | $11,380,000 | +24.9% | 137,411 | 0.0% | 0.49% | +54.1% |
| Q1 2021 | $9,112,000 | -42.1% | 137,411 | -33.0% | 0.32% | -54.4% |
| Q4 2020 | $15,737,000 | -36.6% | 205,091 | -64.4% | 0.70% | -51.1% |
| Q3 2020 | $24,824,000 | -0.3% | 576,505 | 0.0% | 1.44% | -19.6% |
| Q2 2020 | $24,899,000 | +12.6% | 576,505 | -25.0% | 1.78% | -10.9% |
| Q1 2020 | $22,115,000 | -69.8% | 768,674 | -72.2% | 2.00% | -70.8% |
| Q2 2019 | $73,277,000 | +71.5% | 2,765,153 | +18.8% | 6.87% | +61.2% |
| Q1 2019 | $42,728,000 | +47.7% | 2,328,475 | 0.0% | 4.26% | +15.4% |
| Q4 2018 | $28,920,000 | -35.2% | 2,328,475 | 0.0% | 3.69% | -17.9% |
| Q3 2018 | $44,637,000 | +72.7% | 2,328,475 | +22.6% | 4.50% | +35.1% |
| Q2 2018 | $25,840,000 | +88.6% | 1,900,000 | 0.0% | 3.33% | +71.6% |
| Q1 2018 | $13,699,000 | – | 1,900,000 | – | 1.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |